Form 4: Lemaitre Vascular Inc. Executive Acquires Shares Through Dividend Equivalent Rights
Executive Share Acquisition Filing
A Lemaitre Vascular Inc. executive acquired shares through the release of dividend equivalent rights associated with a restricted stock unit award.
Summary
- On December 9, 2024, Bridget A. Ross, an executive at Lemaitre Vascular Inc., acquired shares of common stock.
- The shares were obtained through the release of dividend equivalent rights.
- These rights were associated with a restricted stock unit award granted on December 8, 2023.
- The dividend equivalent rights were released on a one-for-one basis, meaning one right converted to one share.
- Each dividend equivalent right is economically equivalent to one share of Lemaitre's common stock.
Sentiment
Score: 7
Explanation: The document describes a routine executive compensation event, which is generally positive for aligning management and shareholder interests. There are no negative implications.
Positives
- The acquisition of shares by an executive through dividend equivalent rights indicates alignment of interests between management and shareholders.
- The vesting of restricted stock units and release of dividend equivalent rights can be seen as a form of compensation and incentive for executives.
Industry Context
This type of transaction is common in executive compensation packages, where restricted stock units and dividend equivalent rights are used to align executive interests with shareholder value.
Comparison to Industry Standards
- Many publicly traded companies use restricted stock units and dividend equivalent rights as part of their executive compensation packages.
- The one-for-one conversion of dividend equivalent rights to shares is a standard practice.
- Companies like Medtronic and Boston Scientific also use similar compensation methods to incentivize their executives.
Stakeholder Impact
- The share acquisition has a minor positive impact on shareholders by aligning executive interests with company performance.
- The transaction has a positive impact on the executive by providing compensation and incentives.
Key Dates
| Date | Description |
|---|---|
| 2023-12-08 | Date of the restricted stock unit award grant. |
| 2024-12-09 | Date of the share acquisition through dividend equivalent rights. |
| 2024-12-11 | Date of the filing signature. |
Keywords
Lemaitre Vascular Inc, dividend equivalent rights, restricted stock unit, share acquisition, executive compensation, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.